Genes & Diseases,
Год журнала:
2023,
Номер
11(1), С. 148 - 175
Опубликована: Янв. 20, 2023
Chemotherapy
is
an
effortless
and
frequently
used
approach
in
cancer
therapy.
However,
most
cases,
it
can
only
prolong
life
expectancy
does
not
guarantee
a
complete
cure.
Furthermore,
chemotherapy
associated
with
severe
adverse
effects,
one
of
the
major
complications
effective
In
addition,
newly
published
research
outputs
show
that
stem
cells
are
involved
disease
progression,
drug
resistance,
metastasis,
recurrence
they
functional
trans-differentiation
capacity
to
response
treatments.
Novel
strategies
therefore
required
for
better
management
The
prime
would
be
synthesize
develop
novel
drugs
need
extensive
resources,
time,
endurance
brought
into
therapeutic
use.
subsequent
screen
anti-cancer
activity
available
non-cancerous
drugs.
This
concept
repurposing
non-cancer
as
alternative
current
therapy
has
become
popular
recent
years
because
using
existing
anticancer
several
effects.
Micronutrients
have
also
been
investigated
due
their
significant
effects
negligible
or
no
side
availability
food
sources.
this
paper,
we
discuss
ideal
hypothesis
screening
activity,
focus
on
clinical
application
treatment.
Further,
combination
micronutrients
target
both
cancers
may
result
leading
maximum
tumor
growth
control.
The
family
of
aldehyde
dehydrogenases
(ALDHs)
contains
19
isozymes
and
is
involved
in
the
oxidation
endogenous
exogenous
aldehydes
to
carboxylic
acids,
which
contributes
cellular
tissue
homeostasis.
ALDHs
play
essential
parts
detoxification,
biosynthesis,
antioxidants,
are
important
value
for
cell
proliferation,
differentiation,
survival
normal
body
tissues.
However,
frequently
dysregulated
associated
with
various
diseases
like
Alzheimer's
disease,
Parkinson's
especially
solid
tumors.
Notably,
involvement
tumor
progression
responsible
maintenance
stem-cell-like
phenotype,
triggering
rapid
aggressive
clinical
progressions.
have
captured
increasing
attention
as
biomarkers
disease
diagnosis
prognosis.
Nevertheless,
these
require
further
longitudinal
studies
large
populations
broad
application.
This
review
summarizes
our
current
knowledge
regarding
potential
tumors
several
non-tumor
diseases,
well
recent
advances
understanding
functions
underlying
molecular
mechanisms
development.
Finally,
we
discuss
therapeutic
therapy
an
emphasis
on
their
implications.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 17, 2025
Breast
cancer
is
the
most
common
malignant
tumor
in
world,
and
its
metastasis
main
cause
of
death
breast
patients.
However,
differences
between
primary
tissue
lymphatic
node,
bone,
brain
metastases
at
single-cell
level
are
not
fully
understood.
We
analyzed
microenvironment
heterogeneity
samples
(n
=
4),
node
3),
bone
2)
using
sequencing
data
from
GEO
database.
The
epithelial
cells
were
characterized
by
InferCNV
algorithm.
cell-cell
communication
was
CellChat
package.
biological
function
cell
subpopulations
gene
set
variation
analysis.
expression
STMN1
immunohistochemical
staining.
proportion
pCAFs
explored
multispectral
identified
seven
clusters
metastatic
(Lymphatic
brain,
metastases)
analyzing
transcriptomic
profiles.
T-NK
B
dominated
with
metastasis,
whereas
fibroblasts
prevalent
cancer.
five
T
(T
memory,
CD8
+
cells,
regulatory
natural
killer
CD4
cells),
three
(naïve
memory
plasma
cancer-associated
(CAFs)
(Smooth
muscle
(SMC),
pericyte,
antigen-presenting
CAFs
(apCAFs),
proliferative
(pCAFs),
matrix
(mCAFs)).
Notably.
metastasis.
Furthermore,
we
four
subpopulations:
G0,
G1,
G2,
G3.
G2
population
exhibited
strong
invasion
ability,
it
can
differentiate
into
G3
ability
proliferation-related
G1
after
Cell-cell
demonstrated
an
interaction
metastasis-associated
cells.
Finally,
discovered
that
advanced
cancer,
pCAF
increased
associated
a
poor
prognosis
This
study
elucidated
potential
cellular
origins
drivers
to
nodes,
utilizing
prognosis.
Stem Cell Research & Therapy,
Год журнала:
2020,
Номер
11(1)
Опубликована: Ноя. 18, 2020
Abstract
Over
the
last
decades,
cancer
survival
rate
has
increased
due
to
personalized
therapies,
discovery
of
targeted
therapeutics
and
novel
biological
agents,
application
palliative
treatments.
Despite
these
advances,
tumor
resistance
chemotherapy
radiation
rapid
progression
metastatic
disease
are
still
seen
in
many
patients.
Evidence
shown
that
stem
cells
(CSCs),
a
sub-population
share
common
characteristics
with
somatic
(SSCs),
contribute
this
therapeutic
failure.
The
most
critical
properties
CSCs
their
self-renewal
ability
capacity
for
differentiation
into
heterogeneous
populations
cells.
Although
only
constitute
low
percentage
total
mass,
can
regrow
mass
on
own.
Initially
identified
leukemia,
have
subsequently
been
found
cancers
breast,
colon,
pancreas,
brain.
Common
genetic
phenotypic
features
both
SSCs
CSCs,
including
upregulated
signaling
pathways
such
as
Notch,
Wnt,
Hedgehog,
TGF-β.
These
play
fundamental
roles
development
well
control
cell
fate
relevant
targeting
CSCs.
differences
expression
membrane
proteins
exosome-delivered
microRNAs
between
also
important
specifically
target
cancer.
Further
research
efforts
should
be
directed
toward
elucidation
improve
existing
therapies
generate
new
clinically
Cells,
Год журнала:
2021,
Номер
10(11), С. 2981 - 2981
Опубликована: Ноя. 2, 2021
Cancer
stem
cells
(CSCs)
are
a
distinct
subpopulation
of
tumor
with
cell-like
features.
Able
to
initiate
and
sustain
growth
mostly
resistant
anti-cancer
therapies,
they
thought
responsible
for
recurrence
metastasis.
Recent
accumulated
evidence
supports
that
iron
metabolism
the
recent
discovery
ferroptosis
constitutes
promising
new
lead
in
field
anti-CSC
therapeutic
strategies.
Indeed,
uptake,
efflux,
storage
regulation
pathways
all
over-engaged
microenvironment
suggesting
reprogramming
is
crucial
occurrence
cell
survival.
In
particular,
studies
have
highlighted
importance
maintenance
CSCs.
Furthermore,
high
concentration
found
CSCs,
as
compared
non-CSCs,
underlines
their
addiction.
line
this,
if
an
essential
macronutrient
nevertheless
highly
reactive,
it
represents
Achilles’
heel
by
inducing
death
therefore
providing
opportunities
target
this
review,
we
first
summarize
our
current
understanding
its
Then,
provide
overview
knowledge
discuss
role
autophagy
(regulation
of)
ferroptotic
pathways.
Finally,
potential
strategies
could
be
used
CSCs
treat
cancer.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(6), С. 3073 - 3073
Опубликована: Март 12, 2022
Cancer
is
a
disease
exhibiting
uncontrollable
cell
growth
and
spreading
to
other
parts
of
the
organism.
It
heavy,
worldwide
burden
for
mankind
with
high
morbidity
mortality.
Therefore,
groundbreaking
research
innovations
are
necessary.
Research
in
space
under
microgravity
(µg)
conditions
novel
approach
potential
fight
cancer
develop
future
therapies.
Space
travel
accompanied
by
adverse
effects
on
our
health,
there
need
counteract
these
health
problems.
On
cellular
level,
studies
have
shown
that
real
(r-)
simulated
(s-)
µg
impact
survival,
apoptosis,
proliferation,
migration,
adhesion
as
well
cytoskeleton,
extracellular
matrix,
focal
adhesion,
factors
cells.
Moreover,
µg-environment
induces
vitro
3D
tumor
models
(multicellular
spheroids
organoids)
preclinical
drug
targeting,
development,
studying
processes
progression
metastasis
molecular
level.
This
review
focuses
r-
s-µg
different
types
cells
deriving
from
thyroid,
breast,
lung,
skin,
prostate
cancer,
tumors
gastrointestinal
tract.
In
addition,
we
summarize
current
knowledge
cancerous
stem
The
information
demonstrates
has
become
an
important
new
technology
increasing
biology.
Frontiers in Endocrinology,
Год журнала:
2022,
Номер
13
Опубликована: Дек. 8, 2022
Background
Uveal
melanoma
(UVM)
is
the
most
common
primary
intraocular
malignancy
in
adults
and
highly
metastatic,
resulting
a
poor
patient
prognosis.
Sphingolipid
metabolism
plays
an
important
role
tumor
development,
diagnosis,
This
study
aimed
to
establish
reliable
signature
based
on
sphingolipid
genes
(SMGs),
thus
providing
new
perspective
for
assessing
immunotherapy
response
prognosis
patients
with
UVM.
Methods
In
this
study,
SMGs
were
used
classify
UVM
from
TCGA-UVM
GEO
cohorts.
Genes
significantly
associated
screened
using
univariate
cox
regression
analysis.
The
characterized
obtained
by
machine
learning,
4-SMGs
was
constructed
stepwise
multifactorial
cox.
External
validation
performed
GSE84976
cohort.
level
of
immune
infiltration
high-
low-risk
analyzed
platforms
such
as
CIBERSORT.
prediction
checkpoint
blockade
(ICB)
assessed
ImmuCellAI
TIP
portals.
Results
considered
be
strongly
good
predictors
Multivariate
analysis
found
that
model
independent
predictor
UVM,
group
having
higher
overall
survival
than
those
high-risk
group.
nomogram
clinical
characteristics
risk
scores
had
prognostic
power.
showed
better
results
when
receiving
immunotherapy.
Conclusions
excellent
predictive
performance
provided
pre-immune
efficacy,
which
will
facilitate
future
precision
immuno-oncology
studies.
Journal of Personalized Medicine,
Год журнала:
2022,
Номер
12(5), С. 715 - 715
Опубликована: Апрель 29, 2022
The
use
of
biomarkers
in
cancer
diagnosis,
therapy,
and
prognosis
has
been
highly
effective
over
several
decades.
Studies
patients
pre-
post-treatment
during
progression
have
helped
identify
stem
cells
(CSCs)
their
related
microenvironments.
These
analyses
are
critical
for
the
therapeutic
application
drugs
efficient
targeting
prevention
progression,
as
well
investigation
mechanism
development.
Biomarkers
that
characterize
CSCs
thus
identified
correlated
to
prognosis.
However,
demonstrate
elevated
levels
plasticity,
which
alters
functional
phenotype
appearance
by
interacting
with
microenvironments,
response
chemotherapy
radiotherapeutics.
In
turn,
these
changes
induce
different
metabolic
adaptations
CSCs.
This
article
provides
a
review
most
frequently
used
cell
markers.